Donor Site Morbidity of the Medial Sural Artery Perforator (MSAP) Free Flap for Head & Neck Reconstruction.

Head & neck 2025 Vol.47(10) p. 2710-2715

Dattilo LW, de Groot ECM, Nyirjesy S, Karadaghy OA, Noyes E, Spector ME, Richmon JD, Lin DT, Varvares MA, Feng AL

관련 도메인

Abstract

[BACKGROUND] Minimal donor site morbidity is often cited as one of the main advantages of the medial sural artery perforator (MSAP) free flap; however, few studies have examined functional outcomes.

[METHODS] This retrospective cohort study analyzed patients undergoing MSAP for head and neck reconstruction from 2022 to 2024. A modified lower extremity functional scale (LEFS), with 80 being a maximum score, was administered to assess functional morbidity.

[RESULTS] Twenty two patients underwent successful MSAP flap. At < 1 month after surgery, the average LEFS was 56.0 (95% CI, 43.8-68.2). At 1-3 months, the average score was 63.0 (95% CI, 56.0-70.0); at 3-6 months, it was 75.0 (95% CI, 70.0-80.0), and at 6-12 months, it was 78.1 (95% CI, 75.4-80.0). Beyond 12 months, the average score was 79.8 (95% CI, 79.8-80.0).

[CONCLUSIONS AND RELEVANCE] The MSAP free flap is an excellent free tissue option for head & neck reconstruction with minimal donor site morbidity.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 free flap 피판재건술 dict 3
시술 flap 피판재건술 dict 1
해부 Medial Sural Artery Perforator scispacy 1
해부 tissue scispacy 1
합병증 Donor Site scispacy 1
약물 [BACKGROUND] Minimal scispacy 1
약물 [CONCLUSIONS AND scispacy 1
질환 head and neck reconstruction scispacy 1
질환 head & neck reconstruction scispacy 1
질환 Head & Neck scispacy 1
질환 head and neck scispacy 1
기타 patients scispacy 1

MeSH Terms

Humans; Male; Retrospective Studies; Female; Perforator Flap; Middle Aged; Plastic Surgery Procedures; Head and Neck Neoplasms; Aged; Free Tissue Flaps; Transplant Donor Site; Adult; Arteries; Treatment Outcome

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문